Pennington Biomedical is proud to host the 2025 Childhood Obesity Conference, presented by the Greaux Health initiative, on Oct. 3 at its C.B. Pennington, Jr. Conference Center. Guests are also invited to a pre-conference Motivational Interviewing Workshop on Thursday, Oct. 2. Registration is now available on the event’s designated Whova page or at bit.ly/2025BeTheReasonConference. 

Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine. While scientists have long known that maternal difficulty during pregnancy may raise a child’s risk for psychiatric illness, the biological pathways between these prenatal experiences and later mental health have been unclear.

In 2017, a Miami–Berlin flight took an unexpected turn when passengers spotted a rat on board. After landing, the rat was captured and handed over to scientists at the Friedrich-Loeffler-Institut (FLI). There, it was not only seen as a nuisance, but also as an opportunity to examine it as a potential carrier of pathogens. Investigations by scientists from the German Center for Infection Research (DZIF), in collaboration with many other scientists from the “Rodent-borne pathogens network (NaÜPa-net)”, revealed only a few zoonotic and non-zoonotic pathogens. However, the incident underscored how easily pathogens can spread across continents—and why standardized testing of animal stowaways is so important. The findings were recently published in the journal Scientific Reports.

High-grade endometrial carcinoma (HGEC) is an aggressive tumor with increasing incidence and mortality. Traditional classifications, such as Bokhman’s dualistic model and the World Health Organization histopathological system, have limitations due to tumor heterogeneity and interobserver variability. This review provides a comprehensive understanding of how integrating histopathological and molecular data, particularly The Cancer Genome Atlas (TCGA) classification, advances risk stratification and personalized treatment in HGEC. It highlights current challenges and identifies future directions to improve diagnostic accuracy and patient outcomes through precision medicine.

New research in JNCCN validates the use of the “Geriatric Oncology Potentially Inappropriate Medications” (GO-PIMS) scale, from the NCCN Guidelines for Older Adult Oncology, to identify high-risk medications that impact patients and outcomes negatively.